Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High dose vitamin C as an adjuvant therapy in patients with septic shock
TCTR20180925004Phase 2Recruiting
- Sponsor
- Bhumibol Adulyadej Hospital Fund
- Start
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ascorbic acid in septic shock, sponsored by Bhumibol Adulyadej Hospital Fund. Started Sep 2018; status: recruiting.
02
Drugs
ascorbic acid
03
Conditions
septic shock
Beyond the preview
Go deeper on TCTR20180925004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20180925004.